The deletion of the de novo DNA methyltransferase 3 alpha (DNMT3A) in first- or second-generation CAR T cells universally preserved the cell proliferation and antitumor response during prolonged tumor exposure (39). This evidence concerns the gene DNMT3A and neoplasm.